NRx Pharmaceuticals NRXP Highlighted as Top Penny Stock by Wall Street Analysts VF Corporation Draws Jim Cramers Attention as Potential Fantastic Buying Opportunity After Earnings Dip SpaceX IPO Speculation Nvidia Earnings and Bezos on AI Bubble Highlighted in Morning Market Roundup SP 500 Notches Record Close as AI Optimism Drives Micron to 1 Trillion Market Cap Home Depot Reports Mixed Q1 2026 Results Sales Rise Earnings and Return Metrics Fall Chinas Humanoid Robot Ambitions Pose Growing Competition Musk Warns NG Q1 2026 Earnings EPS Beat Amid Ongoing Development Progress HCC Q1 2026 Earnings EPS Misses Estimates as Operating Costs Pressure Results LAUR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher JOYY Q4 2025 Earnings EPS Misses Estimates Amid Widening Losses Shares Slip Sprinklr Inc CXM Q1 2026 Earnings Earnings Beat Drives Optimism Despite Slight Stock Dip CHRW Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Signals Viewbix Inc VBIX Holds Steady at 364 Key Support and Resistance Levels in Focus Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance Ingevity Corporation NGVT Gains 279 as Stock Climbs Toward Key Resistance Brookfield Property Preferred Shares BPYPN Edge Higher Amid Steady Trading Integrated Media Technology IMTE Slides 4 as Stock Tests Key Support Near 047 Kevin Warsh Set to Assume Federal Reserve Chairmanship in White House Ceremony MDWD Q4 2025 Earnings NarrowerThanExpected Loss Offers Cautious Optimism NextTrip Inc NTRP Gains 65 as Shares Bounce from Support Level GormanRupp GRC Q1 2026 Earnings Strong Earnings Beat Drives Analyst Optimism IDYA Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as RD Pipeline Progresses APWC Q3 1997 Earnings Profit Misses Estimates Amid Regional Economic Challenges Smart Powerr Corp CREG Q1 2026 Earnings Narrowed Loss in a Quiet Quarter MXC Q3 2025 Earnings Positive EPS of 022 Amid Quiet Quarter MOMO Q4 2025 Earnings EPS Misses Estimates Shares Decline on Surprise Shortfall Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline